Trial Details

TERMINATED
Basic Information
Clinical ID c1282
Identifier NCT00307827
Trial Title Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Visilizumab
Participant Information
Sponsor Abbott
City Savannah
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2025-04-06
Primary Completion Date 2025-11-07
Completion Date 2025-11-07